Idiopathic aplastic anemia: Diagnosis and classification

Autoimmunity Reviews

Volumn 13, Issue 4-5, 2014, Pages 569-573

  Dolberg, Osnat Jarchowsky ^a,b   Levy, Yair ^a,b  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Aplastic anemia; Autoimmunity; Immunosuppressive therapy; Pancytopenia

Indexed keywords

AUTOANTIBODY; CD34 ANTIGEN; CYTOKINE; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; THROMBOPOIETIN RECEPTOR;

ALLOGENEIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; CLINICAL FEATURE; DISEASE CLASSIFICATION; HUMAN; IDIOPATHIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; PATHOPHYSIOLOGY; REVIEW; T LYMPHOCYTE; TELOMERE;

APLASTIC ANEMIA; AUTOIMMUNITY; IMMUNOSUPPRESSIVE THERAPY; PANCYTOPENIA;

ANEMIA, APLASTIC; ANIMALS; AUTOANTIBODIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; T-LYMPHOCYTES; TELOMERE;

EID: 84896319709     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2014.01.014     Document Type: Review

References (42)

1. Kaufman D., Kelly J., et al. The drug etiology of agranulocytosis and aplastic anemia 1991, 259. Oxford University Press, New York.
2. Aoki K., Fujiki N., Shimizu H., Ohno Y. Geographic and ethnic differences of aplastic anemia in humans. Medullary aplasia 1980, vol. 79. Masson, New York.
3. Mathe G., Amiel J.L., Schwarzenberg L., et al. Bone marrow graft in man after conditioning by antilymphocytic serum. Br Med J 1970, 2:131-136.
4. Young N.S., Maciejewski J. The pathophysiology of acquired AA. N Engl J Med 1997, 336:1365-1372.
5. Hoffman R., Zanjani E.D., Lutton J.D., Zalusky R., Wasserman L.R. Suppression of erythroid-colony formation by lymphocytes from patients with AA. N Engl J Med 1977, 296:10-13.
6. Solomou E.E., Wong S., Visconte V., Gibellini F., Young N.S. Decreased TCR zeta-chain expression in T cells from patients with acquired aplastic anaemia. Br J Haematol 2007 Jul, 138(1):72-76.
7. Risitano A.M., Maciejewski J.P., Green S., Plasilova M., Zeng W., Young N.S. In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing. Lancet 2004, 364(9431):355.
8. Tagoe C., Shah A., Yee H., Belmont H.M. AA in systemic lupus erythematosus: a distinct presentation of acquired AA?. J Clin Rheumatol 2001, 7(6):377-383.
9. Akiyama M., Yanagisawa T., Yuza Y., Yokoi K., Fujisawa K., et al. Severe aplastic anaemia complicating Sjögren syndrome in a 2-year-old girl. J Pediatr 2005, 164(11):700-702. [Epub 2005 Jun 10].
10. de Masson A., Bouaziz J.D., Peffault de Latour R., Benhamou Y., Moluçon-Chabrot C., Bagot M., et al. Severe AA associated with eosinophilic fasciitis: report of 4 cases and review of the literature. SociéG Med (Baltimore) 2013, 92(2):69.
11. Nisticò A., Young N.S. gamma-Interferon gene expression in the bone marrow of patients with AA. Ann Intern Med 1994, 120(6):463.
12. Gu Y., Hu X., Liu C., Qv X., Xu C. Interleukin (IL)-17 promotes macrophages to produce IL-8, IL-6 and tumour necrosis factor-alpha in aplastic anaemia. Br J Haematol 2008, 142(1):109.
13. Du H.Z., Wang Q., Ji J., Shen B.M., Wei S.C., Hou M., et al. Expression of IL-27, Th1 and Th17 in patients with aplastic anemia. J Clin Immunol 2013 Feb, 33(2):436-445.
14. Goto M., Kuribayashi K., Takahashi Y., Kondoh T., Tanaka M., Kobayashi D., et al. Identification of autoantibodies expressed in acquired aplastic anaemia. Br J Haematol Feb 2013, 160(3):359-362.
15. Philpott N.J., Scopes J., Marsh J.C., Gordon-Smith E.C., Gibson F.M. Increased apoptosis in AA bone marrow progenitor cells: possible pathophysiologic significance. Exp Hematol 1995, 23(14):1642-1648.
16. Maciejewski J.P., Selleri C., Sato T., Anderson S., Young N.S. Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia. Br J Haematol 1995, 91(1):245-252.
17. Calado R.T., Young N.S. Telomere maintenance and human bone marrow failure. Blood 2008, 111:4446-4455.
18. Walne A.J., Dokal A., Plagnol V., Beswick R., Kirwan M., de la Fuente J., et al. Exome sequencing identifies MPL as a causative gene in familial aplastic anemia. Haematologica 2012, 97:524-528.
19. Shao W., Tian D., Liu C., Sun X., Zhang X. AA is associated with HLA-DRB1 * 1501 in Northern Han Chinese. Int J Hematol 2000, 7(4):350-352.
20. Szabo S.J., Kim S.T., Costa G.L., Zhang X., Fathman C.G., Glimcher L.H. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000, 100(6):655-669.
21. Scheinberg P., Young N.S. How I treat acquired aplastic anemia. Blood 2012, 120:1185-1196.
22. Gordon-Smith E.C. Acquired aplastic anaemia. Hematology, basic principles and practice 1991, 160-171. Churchill Livingstone, New York. R. Hoffman, E.J. Benz, S.J. Shattil, B. Furie, H.J. Cohen (Eds.).
23. Young N.S., Calado R.T., Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 2006, 108:2509-2519.
24. Marsh J., Ball S.E., Cavenagh J., et al. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol 2009, 147:43-70.
25. Rozman C., Marin P., Nomdedu E., Montserrat E. Criteria for severe aplastic anemia. Lancet 1987, 2:955.
26. Bacigalupo A., Hows J.M., Gluckman E., Nissen C., Marsh J., McCann S., et al. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA Working Party. Br J Haematol 1988, 70:177-182.
27. Kwon J.H., Kim I., Lee Y.G., et al. Clinical course of non-severe aplastic anemia in adults. Int J Hematol 2010, 91(5):770-775.
28. Marsh J., Schrezenmeier H., Marin P., et al. Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anemia Working Party. Blood 1999, 93:2191-2195.
29. Rosenfeld S.J., Kimball J., Vining D., Young N.S. Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood 1995, 85(11):3058-3065.
30. Frickhofen N., Rosenfeld S.J. Immunosuppressive treatment of aplastic anemia with antithymocyte globuilin and cyclosporine. Semin Hematol 2000, 37:56-68.
31. Rosenfeld S., Follman D., Nunez O., Young N.S. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA 2003, 289:1130-1135.
32. Scheinberg P., Nunez O., Young N.S. Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia. Br J Haematol 2006, 133(6):622-627.
33. Di Bona E., Rodeghiero F., Bruno B., et al. Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy: Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Br J Haematol 1999, 107(2):330-334.
34. Scheinberg P., Nunez O., Weinstein B., et al. Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N Engl J Med 2011, 365(5):430-438.
35. Saracco P., Quarello P., Iori A.P., Zecca M., Longoni D., Locasciulli A., et al. Cyclosporin A response and dependence in children with acquired aplastic anaemia: a multicentre retrospective study with long-term observation follow-up. Br J Haematol 2008, 140:197-205.
36. Scheinberg P., Nunez O., Wu C., Young N.S. Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil. Br J Haematol 2006, 133(6):606-611.
37. Scheinberg P., Wu C.O., Nunez O., Boss C., Sloand E.M., Young N.S. Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study. Haematologica 2009, 94(3):348-354.
38. Willis F., Marsh J., Bevan D., Killick S., Lucas G., Griffiths Gordon-Smith E., et al. The effect of treatment with Campath-1H in patients with autoimmune cytopenias. Br J Haematol 2001, 114:891-898.
39. Rosenfeld S., Follmann D., Nunez O., Young N.S. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA 2003, 289(9):1130-1135.
40. Horowitz M.M. Current status of allogeneic bone marrow transplantation in acquired aplastic anemia. Semin Hematol 2000, 37:30-42.
41. Deeg H.J., Leisenring W., Storb R., et al. Long-term outcome after marrow transplantation for severe aplastic anemia. Blood 1998, 91:3637-3645.
42. Marte M., Nunez O., Young N.S. Paroxysmal nocturnal hemoglobinuria clones in severe aplastic anemia patients treated with horse anti-thymocyte globulin plus cyclosporine. Haematologica 2010, 95(7):1075-1080.